Multicenter study to assess the ...
Results from the ENLIGHTEN-2 long-term extension. - APA PsycNet
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results ...
Perlmutter Cancer Center - Clinical Trials - NYU
New life-saving treatments for Resected Solid Tumors and Unresectable Solid Tumors in clinical trial on A Phase 1 Open-Label Multicenter Study to Assess the ...
Interim Analysis Results of an Observational, Retrospective ...
Interim Analysis Results of an Observational, Retrospective, Multicenter Study to Assess the Effectiveness of Fingolimod Treatment in Clinical ...
Clinical Trials - National Organization for Rare Disorders
Is sponsoring a multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating the safety, efficacy, and pharmacokinetics of ...
Search Clinical Trials | Office of Clinical Research - UC Health
Search results for All Clinical Studies. Found 424 clinical studies. A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating The Long- ...
Trial design: This is a randomized, open-label, multi-center, phase II study to assess the impact of early detection of asymptomatic brain mets vs standard ...
Study Protocol of a Prospective Multicenter Study on ... - Frontiers
Ideally, patient-centered trial information material encourages the discussion with the treating physician, and helps patients making trade-offs regarding ...
(ORBEX) Randomized, placebo-controlled, multicenter study to ...
The Oral Bacterial Extract (ORBEX) Study is a three-year study with the goal of identifying if a daily capsule of Broncho-Vaxom®will help prevent or delay ...
Study Title. SELUTION SLR™ 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 ...
A Multicenter Study of Continued Current Therapy vs Transition to ...
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus ...
Shionogi Clinical Trials in the U.S.
) is an investigator-initiated research study, evaluating the safety ... ) is a Phase 1b/2, multicenter, open-label study of S-531011 as monotherapy ...
Ropeginterferon alfa-2b-njft (P1101) - MD Anderson Cancer Center
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in Adult Patients with Essential ...
4575 A Single-Arm, Open-Label, Multicenter Study to ... - Abstract
4575 A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and ...
Reporting assessment of multicenter clinical trial protocols: A cross ...
A cross-sectional literature survey showed the reporting quality of multicenter randomized controlled trials should be improved.
A multicenter research trial is a clinical trial that involves more than one independent medical institutions in enrolling and following trial participants.
Clinical Trials - Mayo Foundation for Medical Education and Research
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs ...
Multicenter study Definition | Law Insider
Define Multicenter study. means the clinical research conducted in multiple research institutions based on the protocol specified in Article 1, ...
Statistical analysis plan for the multicenter, open, randomized ...
This will be the first clinical trial to assess the best antiplatelet therapy to avoid in-stent thrombosis after MT in patients with TL.
A Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy ...
This Phase 3b study of P1101 will provide support for an amended dosing regimen that can achieve a more rapid CHR and optimize treatment of PV.
Study Title. A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon ...